このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Monash IVF Group 過去の業績

過去基準チェック /56

Monash IVF Groupは、平均年間4.2%の収益成長を遂げていますが、 Healthcare業界の収益は、年間成長しています。収益は、平均年間1.5% 9.4%収益成長率で成長しています。 Monash IVF Groupの自己資本利益率は8.5%であり、純利益率は10.2%です。

主要情報

4.2%

収益成長率

-9.5%

EPS成長率

Healthcare 業界の成長	2.4%
収益成長率	9.4%
株主資本利益率	8.5%
ネット・マージン	10.2%
次回の業績アップデート	22 Aug 2024

Recent updates

収支内訳

Monash IVF Group の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。

収益と収入の歴史

CHIA:MVF 収益、費用、利益 ( )AUD Millions
日付	収益	収益	G+A経費
31 Dec 23	236	24	20
30 Sep 23	225	23	19
30 Jun 23	214	22	18
31 Mar 23	204	19	18
31 Dec 22	195	17	18
30 Sep 22	193	18	18
30 Jun 22	192	18	18
31 Mar 22	193	21	18
31 Dec 21	194	23	17
30 Sep 21	189	24	16
30 Jun 21	184	25	14
31 Mar 21	171	22	13
31 Dec 20	159	18	13
30 Sep 20	152	15	12
30 Jun 20	145	12	12
31 Mar 20	149	15	12
31 Dec 19	152	18	12
30 Sep 19	152	19	12
30 Jun 19	152	20	11
31 Mar 19	151	19	14
31 Dec 18	151	19	17
30 Sep 18	151	20	17
30 Jun 18	151	21	17
31 Mar 18	152	24	17
31 Dec 17	153	26	16
30 Sep 17	154	28	16
30 Jun 17	155	30	16
31 Mar 17	156	30	16
31 Dec 16	156	30	15
30 Sep 16	156	29	16
30 Jun 16	157	29	16
31 Mar 16	150	27	13
31 Dec 15	144	24	9
30 Sep 15	134	23	9
30 Jun 15	125	21	9
31 Mar 15	121	15	8
31 Dec 14	117	8	8
30 Sep 14	115	5	8
30 Jun 14	114	3	9
31 Mar 14	110	2	4
31 Dec 13	106	0	0
30 Sep 13	101	-7	3

質の高い収益: MVFは高品質の収益を持っています。

利益率の向上: MVFの現在の純利益率 (10.2%)は、昨年(8.7%)よりも高くなっています。

フリー・キャッシュフローと収益の比較

過去の収益成長分析

収益動向: MVFの収益は過去 5 年間で年間4.2%増加しました。

成長の加速: MVFの過去 1 年間の収益成長率 ( 41.3% ) は、5 年間の平均 ( 年間4.2%を上回っています。

収益対業界: MVFの過去 1 年間の収益成長率 ( 41.3% ) はHealthcare業界-19.1%を上回りました。

株主資本利益率

高いROE: MVFの自己資本利益率 ( 8.5% ) は低いとみなされます。

Monash IVF Group 過去の業績

過去 基準チェック /56

主要情報

最近の業績更新

First half 2024 earnings released: EPS: AU$0.033 (vs AU$0.027 in 1H 2023)

Monash IVF Group Limited to Report First Half, 2024 Results on Feb 23, 2024

Full year 2023 earnings released: EPS: AU$0.056 (vs AU$0.047 in FY 2022)

First half 2023 earnings released: EPS: AU$0.027 (vs AU$0.031 in 1H 2022)

Monash IVF Group Limited to Report First Half, 2023 Results on Feb 21, 2023

Full year 2022 earnings released: EPS: AU$0.047 (vs AU$0.065 in FY 2021)

Recent updates

Monash IVF Group Limited (ASX:MVF)completed the acquisition of 80% stake in Fertility North Holdings Pty Ltd.

Upcoming dividend of AU$0.025 per share

First half 2024 earnings released: EPS: AU$0.033 (vs AU$0.027 in 1H 2023)

Monash IVF Group Limited Appoints Cathy Aston as an Independent Non-Executive Director and A Member of the Audit and Risk Management Committee Effective from 26 February 2024

First half dividend of AU$0.025 announced

Monash IVF Group Limited to Report First Half, 2024 Results on Feb 23, 2024

Upcoming dividend of AU$0.022 per share at 3.5% yield

Monash IVF Group Limited Announces Fully Franked Final Dividend for Fiscal Year Ended June 30, 2023, Payable on 11 October 2023

Full year 2023 earnings released: EPS: AU$0.056 (vs AU$0.047 in FY 2022)

Monash IVF Group Limited Provides Update on Class Action Lawsuit

Monash IVF Group Limited (ASX:MVF) completed the acquisition of PIVET Medical Centre.

Upcoming dividend of AU$0.022 per share at 4.2% yield

First half 2023 earnings released: EPS: AU$0.027 (vs AU$0.031 in 1H 2022)

Monash IVF Group Limited to Report First Half, 2023 Results on Feb 21, 2023

Insufficient new directors

Monash IVF Group Limited (ASX:MVF) completed the acquisition of ART Associates Queensland #2 Pty Ltd.

Upcoming dividend of AU$0.022 per share

Full year 2022 earnings released: EPS: AU$0.047 (vs AU$0.065 in FY 2021)

Monash IVF Group Limited Announces Ordinary Fully Paid Distribution for the Six Months Ended June 30, 2022, Payable on October 7, 2022

Monash IVF Group Limited to Report Fiscal Year 2022 Results on Aug 26, 2022

Monash IVF Group Limited, Annual General Meeting, Nov 11, 2022

Insufficient new directors

Monash IVF Group Limited (ASX:MVF) agreed to acquire PIVET Medical Centre for AUD 9.4 million.

Insufficient new directors

Monash IVF Group Limited Announces Fully Franked Distribution for the Six Months That Ended December 31, 2021, Payable on April 4, 2022

Monash IVF Group Limited to Report First Half, 2022 Results on Feb 17, 2022

Monash IVF Group Limited Updates Temporary Suspension of IVF Procedures Lifted in Victoria

Upcoming dividend of AU$0.021 per share

Full year 2021 earnings released: EPS AU$0.065 (vs AU$0.046 in FY 2020)

Independent Non-Executive Director recently bought AU$192k worth of stock

New 90-day low: AU$0.70

Revenue beats expectations

First half 2021 earnings released: EPS AU$0.037 (vs AU$0.035 in 1H 2020)

New 90-day high: AU$0.80

New 90-day high: AU$0.72

New 90-day high: AU$0.65

Monash IVF Group Limited Provides Earnings Guidance for the Second Half and Full Year of the Fiscal Year 2020

収支内訳

収益と収入の歴史

フリー・キャッシュフローと収益の比較

過去の収益成長分析

株主資本利益率

総資産利益率

使用総資本利益率

過去の好業績企業の発掘

過去基準チェック /56